To ensure the quality and safety of medical services in primary healthcare institutions, China’s National Health Commission (NHC) and other relevant authorities issued a notice on 1 April 2026, outlining a three-year nationwide action.

Microplate-based automatic blood grouping analyzer Metis of Aikang MedTech Co., Ltd. (henceforth referred to as Aikang) received approval for marketing in 2015; and its MGT-based automatic blood grouping analyzer Aigel received approval for marketing in 2016.

On the evening of January 19, Andon Health Co., Ltd. released the 2022 performance forecast, and it is expected that the company's net profit in 2022 will be 16.5 billion CNY to 17.5 billion CNY, a year-on-year increase of 1715.9% to 1825.95%.

Johnson & Johnson announced results for fourth-quarter and full year 2022.

Abbott announced financial results for the fourth quarter ended Dec. 31, 2022.

VieCure today announced a new collaboration with Labcorp to provide clinicians greater access to precision oncology decision support.

Asep Medical Holdings Inc. is pleased to announce that it has signed a joint venture term sheet with a leading Chinese medical diagnostic company, Sansure Biotech Inc. (Sansure).

Thermo Fisher Scientific and AstraZeneca are collaborating on the development of a new solid tissue and blood-based companion diagnostic (CDx) test for Tagrisso (osimertinib).

Roche and its subsidiary TIB Molbiol on Thursday announced that they have developed a COVID-19 polymerase chain reaction (PCR) test that detects and differentiates the latest variant of concern, XBB.1.5.

Hong Kong Science and Technology Parks (HKSTP) announced a strategic collaboration with Roche, one of the world’s largest pharmaceutical companies, with the aim of leading HK and the Greater Bay Area in becoming a pioneer in life science innovation and to be an example for the region.

Roche subsidiary Foundation Medicine announced on Thursday that it is partnering with Boehringer Ingelheim to develop a companion diagnostic for the pharmaceutical firm's biliary tract cancer drug.

On the morning of January 18, the third plenary session of the 14th National People's Congress of Hunan Province was held to elect 118 delegates of Hunan Province to the 14th National People's Congress, and Dai Lizhong, President of Sansure Bio, was elected.